India's animal testing rules must advance nation, not regress: Gandhi

New guidelines on animal testing in India have become the subject of scrutiny as stakeholders debate whether regulatory reforms will modernize the country's research framework or compromise welfare standards.

Maneka Gandhi, a prominent voice on animal welfare issues, has emphasized that any revision to testing protocols must represent progress rather than a step backward. Her comments reflect broader concerns within animal advocacy circles about balancing India's scientific advancement with ethical considerations.

Government authorities have defended the regulatory changes, maintaining they are designed to expedite approval procedures for research institutions, pharmaceutical companies, and biomedical enterprises. Officials argue that simplifying the approval mechanism will reduce bureaucratic delays while maintaining necessary oversight.

The revised rules come as India seeks to strengthen its position as a global hub for pharmaceutical and biomedical research. Policymakers contend that streamlined processes will enhance competitiveness without compromising standards, though the specifics of proposed changes and their implications remain subjects of ongoing discussion among industry groups, regulators, and animal welfare advocates.